Faruqi & Faruqi, LLP Investigates Potential Claims for Semler Scientific Investors Ahead of Deadline
Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is currently investigating potential claims against Semler Scientific, Inc. (NASDAQ: SMLR), concerning the possibility of class action lawsuits. This investigation is particularly important for investors who acquired shares of Semler Scientific between March 10, 2021, and April 15, 2025. Potential plaintiffs are reminded that the deadline to act is quickly approaching, with a cut-off date of October 28, 2025, for those looking to be recognized as lead plaintiffs in the ongoing federal securities class action.
The investigation arose after troubling disclosures were made by Semler Scientific, revealing that the company did not inform the shareholders about a significant investigation by the United States Department of Justice (DOJ). This inquiry is focused on violations related to the False Claims Act—serious allegations that can influence stock performance significantly. Semler's failure to adequately disclose this investigation could constitute a breach of federal securities laws, leading to the legal action now being pursued by Faruqi & Faruqi.
On February 28, 2025, Semler filed its annual report, which revealed that on February 11, 2025, discussions regarding a potential settlement with the DOJ had initially commenced but were halted that same day. This information prompted a swift reaction from the market, leading to a substantial drop of over 9% in Semler's stock valuation during the trading session that followed.
James (Josh) Wilson, a Senior Partner at Faruqi & Faruqi, urges any investors who suffered losses during this period to reach out directly for more information regarding their legal rights and options. Investors who wish to pursue claims against Semler for their losses are strongly encouraged to contact the firm and discuss their situation.
Being named as a lead plaintiff in class action lawsuits can be a critical position, as it involves directing the suit on behalf of all affected shareholders. Investors can choose to seek this role with legal representation or remain passive class members, not affecting their eligibility for any potential recoveries arising from the case.
Faruqi & Faruqi emphasize that they are interested in hearing from anyone with information related to Semler Scientific's operations, including whistleblowers, former employees, and shareholders. The firm hopes to create a comprehensive view of the company's practices to support their claims and strengthen the case against Semler Scientific.
To learn more about initiating a claim or participating in the existing investigation, interested investors can visit the firm's website or contact Josh Wilson directly at the provided phone numbers. Since its establishment in 1995, Faruqi & Faruqi has successfully recovered hundreds of millions of dollars for investors, demonstrating a solid track record in securities litigation. As the deadline approaches, they stress the urgency for affected investors to take action and assert their rights effectively.
For continuous updates regarding the Semler Scientific situation, investors can also follow Faruqi & Faruqi on LinkedIn, X, or Facebook. The firm assures confidentiality in all communications and is fully prepared to assist those who have been impacted by the alleged wrongdoing of Semler Scientific.
The investigation arose after troubling disclosures were made by Semler Scientific, revealing that the company did not inform the shareholders about a significant investigation by the United States Department of Justice (DOJ). This inquiry is focused on violations related to the False Claims Act—serious allegations that can influence stock performance significantly. Semler's failure to adequately disclose this investigation could constitute a breach of federal securities laws, leading to the legal action now being pursued by Faruqi & Faruqi.
On February 28, 2025, Semler filed its annual report, which revealed that on February 11, 2025, discussions regarding a potential settlement with the DOJ had initially commenced but were halted that same day. This information prompted a swift reaction from the market, leading to a substantial drop of over 9% in Semler's stock valuation during the trading session that followed.
James (Josh) Wilson, a Senior Partner at Faruqi & Faruqi, urges any investors who suffered losses during this period to reach out directly for more information regarding their legal rights and options. Investors who wish to pursue claims against Semler for their losses are strongly encouraged to contact the firm and discuss their situation.
Being named as a lead plaintiff in class action lawsuits can be a critical position, as it involves directing the suit on behalf of all affected shareholders. Investors can choose to seek this role with legal representation or remain passive class members, not affecting their eligibility for any potential recoveries arising from the case.
Faruqi & Faruqi emphasize that they are interested in hearing from anyone with information related to Semler Scientific's operations, including whistleblowers, former employees, and shareholders. The firm hopes to create a comprehensive view of the company's practices to support their claims and strengthen the case against Semler Scientific.
To learn more about initiating a claim or participating in the existing investigation, interested investors can visit the firm's website or contact Josh Wilson directly at the provided phone numbers. Since its establishment in 1995, Faruqi & Faruqi has successfully recovered hundreds of millions of dollars for investors, demonstrating a solid track record in securities litigation. As the deadline approaches, they stress the urgency for affected investors to take action and assert their rights effectively.
For continuous updates regarding the Semler Scientific situation, investors can also follow Faruqi & Faruqi on LinkedIn, X, or Facebook. The firm assures confidentiality in all communications and is fully prepared to assist those who have been impacted by the alleged wrongdoing of Semler Scientific.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.